Scheduling Aseptic Filling For Preclinical And Clinical Batches

A biopharmaceutical sponsor’s selection of a CDMO partner is a matter of finding the appropriate partner for a particular job. While a prospective partner’s qualifications may appear acceptable on paper, its company culture, the priority it places on a client’s project, or its availability to schedule client aseptic filling runs may not make it a good fit.

Drug Development and Project Scheduling Challenges

Operating in the drug development space — primarily for small-batch aseptic manufacturing for preclinical and clinical use — Singota is keenly aware of the project scheduling challenges faced by our clients. We have built our business with the understanding that many factors affect drug development timelines, from the intricacies of cutting-edge chemistry to the unpredictable-at-times availability of raw materials, that are often beyond our clients’ control.